Endpoints News 9. Dez. 2025 #ASH25: Eli Lilly's Jaypirca makes first-line case, but ceiling may be capped
Endpoints News 8. Dez. 2025 Structure Therapeutics’ obesity pill stacks up with Novo and Lilly; Ascletis also reports early results
Endpoints News 24. Nov. 2025 Nobel laureate Carolyn Bertozzi to rejoin Lilly board #Carolyn Bertozzi #Eli Lilly
Endpoints News 21. Nov. 2025 Novo, Lilly begin to sell obesity medications directly to employers #Novo Nordisk #Eli Lilly